Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1287
https://www.valueinhealthjournal.com/article/S1098-3015(15)03363-X/fulltext
Title :
Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03363-X&doi=10.1016/j.jval.2015.09.1287
First page :
A477
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
785